Long term follow-up of patients with medullary carcinoma of the thyroid

Cancer

Volumn 79, Issue 1, 1997, Pages 132-138

  Bergholm, Ulla ^a   Bergström, Reinhold ^a,b   Ekbom, Anders ^a,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

clinical characteristics; familial occurrence; medullary carcinoma of the thyroid; survival

Indexed keywords

AMYLOID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, MEDULLARY; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 0031014504     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5     Document Type: Article

References (25)

1. Bergholm U, Adami HO, Bergström R, Bäckdahl M, Åkerström G, and the Swedish MTC study group. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. Acta Chir Scand 1990;156:37-46.
2. Bergholm U, Adami HO, Auer G, Bergström R, Bäckdahl M, Grimelius L, et al. Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. Cancer 1989:64:135-42.
3. Pyke CM, Hay ID, Goellner JR, Bergstrahl EJ, van Heerden JA, Grant CS. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery 1991; 110:964-71.
4. Pelizzo MR, Bernante P, Piotto A, Toniato A, Girelli ME, Busnardo B, et al. The extent of surgery for thyroid medullary cancer. Tumori 1994;80:427-32.
5. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990;212:395-401.
6. Gharib H, McConahey WM, Tiegs RD, Bergstrahl EJ, Goellner JR, Granr CS, et al. Medullary thyroid carcinoma:clinopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 1992; 67:934-40.
7. Schröder S, Böcker W, Baisch H, Burk CG, Arps H, Meiners I, et al. Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry and DNA content. Cancer 1988;61:806-16.
8. Bergholm U, Adami HO, Telenius-Berg M, Johansson H, Wilander E, and the Swedish MTC study group. Incidence of sporadic and familial medullary thyroid carcinoma in Sweden 1959 through 1981. Acta Oncol 1990;29:9-15.
9. Bergholm U, Adami HO, Bergström R, Johansson H, Lundell G, Telenius-Berg M, et al. Clinical characteristics in sporadic and familial medullary thyroid carcinoma. Cancer 1989; 63:1196-204.
10. Telenius-Berg M. Diagnostic studies in medullary carcinoma of the thyroid. New methods for early diagnosis in families with Sipple's syndrome. Thesis Lund 1976. Acta Med Scand 1977;Suppl 597:60.
11. Tallroth Ekman E, Bergholm U, Bäckdahl M, Adami HO, Bergström R, Grimelius L, et al. Nuclear DNA content and survival in medullary thyroid carcinoma. Cancer 1990; 65:511-7.
12. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Monogr Natl Cancer Inst 1961; 6:101-21.
13. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analyses. Comput Programs Biomed 1985;19:197-207.
14. Greenwood M. The errors of sampling of the survivorship tables. In: Reports on public health and medical subjects. No. 33. Appendix I. London: Her Majesty's Stationary Office, 1926.
15. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
16. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CSJ, Hickey RL, et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 1984;63:319-42.
17. Brunt LM, Wells SA Jr. Advances in the diagnosis and treatment of medullary thyroid carcinoma. Surg Clin North Am 1987;67:263-79.
18. Rougier P, Parmentier C, Laplanche A, Lefevre M, Travagli JP, Caillou B, et al. Medullary thyroid carcinoma:prognostic factors and treatment. Int J Radiat Oncol Biol Phys 1983;9:161-9.
19. Wells SA Jr., Baylin SB, Leight GS, Dale RN, Dilley WG, Farnoon JR. The importance of eariy diagnosis in patients with hereditary medullary thyroid carcinoma Ann Surg 1982;195:595-9.
20. Duh QY, Sancho JJ, Greenspan FS, Hunt TK, Galante M, deLorimier AA, et al. Medullart thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg 1989;124:1206-10.
21. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M, Herfarth C. Medullary carcinoma of the thyroid: therapeutic strategy derived from fifteen years of experience. Surgery 1993;114:491-6.
22. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986;99:60-6.
23. Brumsen C, Haak HR, Gosling BM, van de Velde CJ. Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival? Henry Ford Hosp J 1992;40:271-5.
24. Buhr HJ, Lehnert T, Raue F. New operative strategy in the treatment of metastasizing medullary carcinoma of the thyroid Eur J Surg Oncol 1990;16:366-9.
25. Block MA Surgical treatment of medullary carcinoma of the thyroid. Otolaryngol Clin North Am 1990;23:453-73.